Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × COVID-19 × avdoralimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Infections 1 COVID-19 1

Interventions

Blood Specimen Collection 6 Surveys and Questionnaires 5 Standard of Care 5 BNT162 Vaccine 5 Surgical Procedures, Operative 3 Specimen Handling 3 Practice Guidelines as Topic 3 Hydroxychloroquine 3 COVID-19 Vaccines 3 2019-nCoV Vaccine mRNA-1273 3 tocilizumab 2 sotrovimab 2 Pandemic Preparedness 2 CVnCoV COVID-19 vaccine 2 Azithromycin 2 sinovac COVID-19 vaccine 1 selinexor 1 remdesivir 1 ogalvibart 1 monalizumab 1 lenzilumab 1 heterologous prime boost COVID-19 vaccination 1 crexavibart 1 cilgavimab and tixagevimab drug combination 1 ciclesonide 1 avdoralimab 1 XAV-19 1 Therapeutics 1 Telemedicine 1 Sperm Count 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04333914 2022-09-30

IMMUNONCOVID

Centre Leon Berard

Phase 2 Completed

COVID-19, Infections, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡